Next Century Growth Investors’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Next Century Growth Investors’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-115,566	Closed	-$2.44M	–	200
2015 Q3	$2.44M	Buy	115,566 +5,002	+5%	+$171K	0.1%	155
2015 Q2	$5.47M	Buy	+110,564	New	+$6.61M	0.19%	148

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Next Century Growth Investors's OREX Position: Q4 2015 in Review

Next Century Growth Investors sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2015, closing a stake of 115,566 shares — an estimated $2.44M sold.

Next Century Growth Investors first reported a position in OREX in Q2 2015 and held it in 2 quarters. The position peaked at $5.47M in Q2 2015. 121 funds tracked by Wall St. Rank hold OREX as of Q4 2015.

Next Century Growth Investors reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Next Century Growth Investors sold 115,566 Orexigen Therapeutics, Inc. shares in Q4 2015, an estimated $2.44M.
Next Century Growth Investors first reported a position in Orexigen Therapeutics, Inc. in Q2 2015 and held it in 2 quarters.
Next Century Growth Investors's Orexigen Therapeutics, Inc. position peaked at $5.47M in Q2 2015.
121 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2015.

Based on Next Century Growth Investors's 13F filing for Q4 2015, filed 12 Feb 2016.